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September 2009704 Abstractsrecorded. ABI  0.9 was considered equivalent to moderate-to-high CHD
risk (10%).
Results: ABI  0.9 prevalence was 4.5%. Only 0.62% presented low
ABI and IC. Age, current smoker, cardiovascular disease, and uncontrolled
hypertension independently associated with ABI  0.9 in both sexes; ICwas
also associated in men and diabetes in women. Among participants 35–74
free of cardiovascular disease, 6.1% showed moderate-to-high 10-year CHD
risk; adding ABI measurement yielded 8.7%. Conversely, the risk function
identified 16.8% of these participants as having 10-year CHD risk  10%. In
participants 75–79 free of cardiovascular disease, the prevalence of
ABI  0.9 (i.e., CHD risk  10%) was 11.9%.
Conclusions: ABI  0.9 is relatively frequent in those 35–79, partic-
ularly over 74. However, IC and CHD risk  10% indicators are often
missing. Adding ABI measurement to CHD-risk screening better identifies
moderate-to-high cardiovascular risk patients.
Subintimal Angioplasty: Meta-analytical Evidence of Clinical Utility
Bown M.J., Bolia A., Sutton A.J. Eur J Vasc Endovasc Surg 2009;38:323-
337.
Objectives: The aim of this study was to determine accurate estimates
of the success rate of subintimal angioplasty in terms of ability to recanalise
occluded vessels, patency over time and limb salvage rates.
Design: A meta-analysis of published literature.
Materials: All studies reporting unique patient data published in
English language between 1989 and 2008.
Methods: Separate meta-analyses were performed for immediate tech-
nical success, 12-month patency rates and 12-month limb salvage rates.
Longer-term outcomes were analyzed in separate meta-analyses. Meta-
regression was applied to determine whether any of these outcomes had
improved over time.
Results: Pooled estimates for technical success, primary patency at 12
months and limb salvage at 12 months were 85.7% (95% confidence interval:
83.3%–87.7%, 2810 limbs), 55.8% (95% confidence interval: 47.9%–63.4%,
1342 limbs), and 89.3% (95% confidence interval: 85.5%–92.2%, 2810 limbs),
respectively. Regression analysis demonstrated no significant change in out-
comes over time. There was some evidence of publication bias, however, after
adjusting for this there was little change in the pooled outcome estimates.
Conclusions: This study demonstrates that the outcomes for subinti-
mal angioplasty are good and that this method should be considered as an
alternative to surgical bypass.
A 15-Year Experience with Combined Vascular Reconstruction and
Free Flap Transfer for Limb-Salvage
RandonC., Jacobs B., De Ryck F., Van Landuyt K., Vermassen F. Eur J Vasc
Endovasc Surg 2009;38:338-345.
Objectives: To evaluate the results and complications of combined
simultaneous arterial re-vascularisation and free flap transfer in patients with
critical limb ischaemia and large soft-tissue defects that would otherwise
have required major amputation.Design: Retrospective analysis of all combined procedures performed
between 1993 and 2007 with regard to complications and outcome.Materials and methods: Seventy-eight procedures were performed in
76 patients with a mean age of 60 years (range: 18–80 years). The majority
had diabetes (70.5%). Follow-up was obtained from hospital charts and
telephone contacts with patients or GPs.
Results: The limb-salvage rate was 93% after 1 year, 80% after 3 years
and 71% after 5 years. Perioperative complications occurred in 50% of the
patients; six out of 78 (7.7%) arterial reconstructions and 13 out of 78
(16.7%) flaps had to be revised during the early postoperative period.
However, most flaps could be saved by a secondary procedure resulting in an
early failure (amputation) rate of 6%.
In-hospital mortality was 3.8%. End-stage renal disease was the only
factor predicting limb loss. In total, 65% of the patients survived and were
able to walk on their reconstructed limb at 1-year follow-up. Combined
survival and limb-salvage rates were 85%, 66% and 51% after 1, 3 and 5 years.
Conclusions: Combined arterial re-vascularisation and free flap trans-
fer can be performed safely with acceptable morbidity and mortality and
should be considered for every mobile patient with large soft-tissue deficit
(10 cm2) without end-stage renal disease prior to major amputation.
Lower-extremity Arteriovenous Access for Haemodialysis: A System-
atic Review
Antoniou G.A., Lazarides M.K., Georgiadis G.S., Sfyroeras G.S., Nikolo-
poulos E.S., Giannoukas A.D. Eur J Vasc Endovasc Surg 2009;38:365-372.
Background: The lower extremity is increasingly used as an access site in
end-stage renal disease patients. However, reports present conflicting results,
creating confusion regarding the feasibility and outcomes. Our objective is to
review the available literature and analyse the patency rates and complications of
various types of lower-extremity arteriovenous access.
Methods: An Internet-based literature search was performed using
MEDLINE to identify all published reports on lower-extremity vascular
access. The analysis involved studies comprising at least 10 arteriovenous
accesses with both inflow and outflow vessels in the lower extremity, and
reporting on patency rates and access-related complications. The weighted
mean patency rates were calculated, and the chi-square (2) test was used to
evaluate the differences in the complication rates in the subgroups of patients
identified.
Results: Three main types of lower-extremity vascular access were
identified: the upper thigh prosthetic, the mid-thigh prosthetic and the
femoral vein transposition arteriovenous access. There are limited data on
saphenous vein loop grafts, which report poor results. The weighted mean
primary patency rates at 12 months were 48%, 43% and 83%, respectively.
The weighted mean secondary patency rates at 12 months were 69%, 67%
and 93%, respectively. Access loss as a result of infection was more common
in upper thigh and mid-thigh grafts than femoral vein transposition arterio-
venous access (18.40%, 18.33% vs. 1.61%; P  0.05). Ischaemic complica-
tions rates were higher in autologous than prosthetic arteriovenous access
(20.97% vs. 7.18%, P  0.05).
Conclusions: Lower-extremity vascular access has acceptable results in
terms of patency, with femoral vein transposition having better patency rates
than femoral grafts. Autologous access is associated with less infective
complications, however, at the expense of increased ischaemic complications
rates. Further research with randomised trials is required to assess the
outcomes of lower-extremity vascular access.
